Rather than lamenting the distance from Silicon Valley, top European founders frame their location as an advantage. They become the undisputed top company for ambitious, loyal, and less-expensive talent in cities like Stockholm or Warsaw, attracting engineers eager for a generational opportunity.

From its inception as a US company, Poolside made a conscious decision not to hire researchers in the Bay Area. Instead, they built a fully remote, global team, anticipating the intense talent war. This strategy initially slowed them down but eventually provided a competitive advantage in talent acquisition.

Despite high costs, San Francisco's dense network of builders provides access to crucial, unwritten knowledge ('whispered secrets') that accelerates ambitious startups. Moving to SF also acts as a powerful selection filter for founder commitment, creating a unique, high-focus environment that is difficult to replicate.

Fintech giant Ramp attributes its early hiring success to building in New York City. Unlike the hyper-competitive, short-tenure culture of Silicon Valley at the time, NYC offered a pool of talented engineers seeking long-term roles. This talent arbitrage allowed Ramp to build a stable, high-quality team and "punch way above its weight."

Instead of competing for expensive sales talent in hubs like San Francisco, startups can find better value and alignment in cities like Phoenix or Austin. The talent there is often more willing to bet on themselves with high-commission, lower-base salary packages, which is ideal for a startup's growth stage and capital efficiency.

Despite YC's push to stay in San Francisco, Hera's founders are returning to Berlin. They believe they can hire top AI talent more affordably and with less competition than in the Bay Area. Since their product is global and consumer-facing, an SF presence isn't critical for customer acquisition.

Europe's decentralized biotech ecosystem offers a major operational advantage over hubs like Boston. Lower competition for talent, lab space, and clinical trial sites allows startups to operate at 50% of the cost, coupled with pre-money valuations that are often 40% lower, creating significant capital efficiency.

While biotech hubs like Boston offer a larger talent pool, companies in emerging hubs may benefit from higher employee retention. With fewer local competitors, top talent is less likely to be poached, creating more stable teams, a trade-off investors consider.

The density of information in Silicon Valley leads to a 'fast follower' effect where successful ideas are immediately copied. VCs are investing in other geographies to find startups in less crowded, often harder-to-build categories (hardware, regulated industries) with more durable competitive advantages.